Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q1 2024 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2024-04-15

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: Apr 15, 2024

Total Value: $449M (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 50.2%

Value $226M Shares 19,963,157 Est. Cost $20.88 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 17.6%

Value $79.27M Shares 7,464,572 Est. Cost $13.72 Unrealized -38.1%

NAMS NEWAMSTERDAM PHARMA COMPANY 15.1%

Value $67.87M Shares 2,869,565 Est. Cost $10.96 Unrealized +85.3%

— MERUS N V 11.7%

Value $52.64M Shares 1,169,028 Est. Cost $14.08 Unrealized —

AURA AURA BIOSCIENCES INC 5.3%

Value $23.86M Shares 3,039,892 Est. Cost $17.87 Unrealized -53.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$226M	50.2%	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$79.27M	17.6%	$13.72	-38.1%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$67.87M	15.1%	$10.96	+85.3%	ORDINARY SHARES	N62509109
—	MERUS N V	1,169,028	$52.64M	11.7%	$14.08	—	COM	N5749R100
AURA	AURA BIOSCIENCES INC	3,039,892	$23.86M	5.3%	$17.87	-53.6%	COM	05153U107